Sanofi Consumer Healthcare India Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- ✓Attractively valued vs sector (P/E 41.7x vs industry 54.4x)
- ✓Virtually debt-free
- ✓Regular dividends — yield 1.6%
Concerns
- ✗High premium to book value (P/B 28x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
SANOFICONR · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 60.40% | 60.40% | 71.27% | 71.27% | 71.27% | 71.27% |
| FII | 4.42% | 4.52% | 3.24% | 2.94% | 2.83% | 2.76% |
| DII | 25.35% | 25.48% | 16.89% | 17.21% | 17.33% | 17.57% |
| Public | 9.84% | 9.59% | 8.59% | 8.58% | 8.57% | 8.41% |
Corporate Events
Dividend - Rs 75 Per Share
Dividend - Rs 55 Per Share
Latest News
All news →Sanofi India shares unaffected by routine regulatory filing
*Sanofi India shares unaffected by routine regulatory filing.* The company submitted a general update to the NSE under SEBI listing regulations. No financial or operational impact is expected from this disclosure. It is a standard compliance requirement with no material changes reported. 📊 *STOCKS:* SANOFI | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Regulatory
Sanofi India auditor resigns over unpaid fees
*Sanofi India auditor resigns over unpaid fees* — Statutory auditor of Sanofi Consumer Healthcare India has resigned due to a fee disagreement. The resignation raises concerns over corporate governance and audit continuity. Financial implications and impact on reporting timelines remain under review. A new auditor will need to be appointed promptly to avoid delays in regulatory filings. 📊 *STOCKS:* SANOFIINDIA | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #AuditorResignation
Sanofi India forward P/E ratio updated on TradingView
*Sanofi India forward P/E ratio updated on TradingView.* The data reflects revised earnings expectations, though no fundamental change in operations was reported. **Forward P/E** stands at **34.2x** as per latest metrics. This update is informational for traders assessing valuation multiples. 📊 *STOCKS:* SANOFI | 🏢 *SECTOR:* Pharma | #LOWIMPACT #P/Eratio
Sanofi India partners with MP govt for NCD, rare disease care
*Sanofi India partners with MP govt for NCD, rare disease care.* The collaboration with NHM Madhya Pradesh aims to enhance healthcare access for non-communicable and rare diseases. While the move supports long-term patient outreach, it does not involve a significant financial outlay. No immediate revenue impact is expected. 📊 *STOCKS:* SANOFI | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Pharma